太龍藥業(600222.SH):5%以上股東吳瀾減持期過半未實施減持
格隆匯5月25日丨太龍藥業(600222.SH)公佈,公司於2020年2月4日發佈了《關於股東集中競價減持股份計劃公告》,5%以上股東吳瀾擬在2020年2月25日至2020年8月23日期間通過集中競價方式,減持其持有的公司股份總數不超過600萬股,減持比例不超過公司總股本的1.05%。截至本公告披露日,吳瀾本次減持計劃時間已過半,未減持其持有的公司股份。本次減持計劃尚未實施完畢。
截至本公告披露日,吳瀾持有公司無限售條件流通股3453.65萬股股份,佔公司總股本的比例為6.02%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.